Evaluation of a Noninvasive Fetal RHD Genotyping Test

Completed

Conditions studied: Rhesus D Genotype

In brief

This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.

Key facts

Study ID

NCT01054716

Run by

Sequenom, Inc.

People needed

500

Starts

2009-05-01

Expected to finish

2010-11-01

Last updated by the study team

2011-09-05

Who can join

Age: 18 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 18-64 years of age
• Subject is female
• Subject is pregnant
• Subject is RhD negative
• Subject is between 10 and 28 weeks gestation
• Subject provides informed consent
• Subject agrees to provide neonatal RHD and sex outcome

You may not qualify if…

• None

Where it is running

• Sharp Grossmont Hospital — San Diego, California, United States
• West Coast OBGYN — San Diego, California, United States
• Women's Health Care, Inc — San Diego, California, United States
• Scripps Hospitals (5 San Diego locations) — San Diego, California, United States
• Spectrum Health Research — Grand Rapids, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.